ROYALTY PHARMA OA DL-0001 revenue breakdown overview

ROYALTY PHARMA OA DL-0001 revenue for the last year amounted to 2.76 B EUR, the most of which — 2.13 B EUR — came from its highest performing source at the moment, Biopharmaceutical Royalties, the year earlier bringing 2.09 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ROYALTY PHARMA OA DL-0001 2.13 B EUR, and the year before that — 2.09 B EUR.